.AstraZeneca has actually discussed a very early consider the performance of its own in-house antibo...
.After introducing a stage 3 launch based upon positive midstage results, iTeos and also GSK are act...
.The FDA ought to be extra available as well as collaborative to release a rise in commendations of ...
.It's an uncommonly busy Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicara Rehabs a...
.Atea Pharmaceuticals' antiviral has actually failed an additional COVID-19 test, however the biotec...
.Neurocrine Biosciences' schizophrenia system pivot has actually fallen short. The biotech was not a...
.Sanofi has actually made an overdue entrance to the radioligand event, paying 100 thousand euros ($...
.After F2G's 1st attempt to get a new course of antifungal to market was hindered due to the FDA, th...
.Moderna has actually promised to reduce R&D spending through $1.1 billion by 2027. The decision ...
.Simply 4 months after Sanofi bet $80 million in upfront cash on Pivot Rehabs' losmapimod, the plan ...